SPL 2.13% 9.6¢ starpharma holdings limited

Ann: DEP irinotecan synergistic with Lynparza in refractory model, page-2

  1. 2,246 Posts.
    lightbulb Created with Sketch. 323
    Great news...... SP will not budge much though, this is just another mice trail readout!

    SPL PLEASE invest more money on your recruitment centers and speed up the current trail recruitment process!!!
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.